Search is Powered by Google
Cancer / Oncology News

Leading US Cancer Researcher Receives New Swedish Science Prize

Main Category: Cancer / Oncology
Also Included In: Genetics
Article Date: 30 Jan 2008 - 4:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

The American cancer research pioneer Professor Robert A Weinberg is the first recipient of the science prize inaugurated by the foundation set up by Swedish scientists Georg and Eva Klein. The prize was awarded in person by Crown Princess Victoria at a ceremony in Stockholm on 29 January 2008. The prizewinner, who is a leading international researcher in his or her field, is invited to Karolinska Institutet in Stockholm for two weeks to give lectures and forge links with research leaders, postgraduates and visiting researchers.

Professor Weinberg works at the Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology. He has made a number of pioneering discoveries in basal tumour biology. His research demonstrates, for example, how genes and the proteins they control combine to convert a healthy cell into a cancer cell. He has also made important discoveries on how tumour suppressant genes (TSGs) can prevent the development of tumours. Understanding these processes will make it easier for scientists to find effective treatments for different kinds of cancer.

"Robert A Weinberg is a cancer researcher with an extremely high international reputation," says associate professor Marie Arsenian Henriksson at Karolinska Institutet. "We are very pleased that he agreed to come to Sweden to talk about his research."

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

Karolinska Institutet is one of the leading medical universities in Europe. Through research, education and information, Karolinska Institutet contributes to improving human health. Each year, the Nobel Assembly at Karolinska Institutet awards the Nobel Prize in Physiology or Medicine. For more information, visit http://ki.se/

Source: Sabina Bossi
Karolinska Institutet




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
Shocking Pictures To Appear On Cigarette Packets In UK On 1st October
27 Sep 2008
The UK's ten million Smokers may see pictures of rotting teeth, throat cancer, and indications of male impotence (erectile dysfunction) on cigarette packets they buy at the beginning of October...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...